Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm

por Trad, Karim S., Fox, Mark A., Simoni, Gilbert, Shughoury, Ahmad B., Mavrelis, Peter G., Raza, Mamoon, Heise, Jeffrey A., Barnes, William E.
Publicado 2016

Transoral Incisionless Fundoplication Effective in Eliminating GERD Symptoms in Partial Responders to Proton Pump Inhibitor Therapy at 6 Months: The TEMPO Randomized Clinical Trial

por Trad, Karim S., Barnes, William E., Simoni, Gilbert, Shughoury, Ahmad B., Mavrelis, Peter G., Raza, Mamoon, Heise, Jeffrey A., Turgeon, Daniel G., Fox, Mark A.
Publicado 2015

Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, m...

por Trad, Karim Sami, Simoni, Gilbert, Barnes, William Edris, Shughoury, Ahmad Bassel, Raza, Mamoon, Heise, Jeffrey Alan, Turgeon, Daniel Gilles, Fox, Mark Alan, Mavrelis, Peter George
Publicado 2014

The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective

por Trad, Karim S., Barnes, William E., Prevou, Elizabeth R., Simoni, Gilbert, Steffen, Jennifer A., Shughoury, Ahmad B., Raza, Mamoon, Heise, Jeffrey A., Fox, Mark A., Mavrelis, Peter G.
Publicado 2018